Uridine diphosphate glucuronosyltransferase 2b7 variant p.his268tyr as a predictor of kidney allograft early acute rejection

Transplantation Proceedings

Volumn 45, Issue 4, 2013, Pages 1516-1519

  Pazik, J ^a   Oldak M ^a   Lewandowski, Z ^a   Podgorska M ^a   Sitarek, E ^a   Ploski R ^a   Galazka Z ^a   Kwiatkowski, A ^a   Malejczyk, J ^a   Durlik, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLOSPORIN A; DACLIZUMAB; GENOMIC DNA; GLUCURONOSYLTRANSFERASE 2B7; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; CONFERENCE PAPER; DELAYED GRAFT FUNCTION; GASTROINTESTINAL SYMPTOM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRANULOCYTOPENIA; HETEROZYGOTE; HLA MATCHING; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; LEUKOPENIA; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETRANSPLANTATION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; TIME;

ADULT; BIOLOGICAL MARKERS; FEMALE; GLUCURONOSYLTRANSFERASE; GRAFT REJECTION; HISTIDINE; HUMANS; ISOENZYMES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME; TYROSINE;

EID: 84878597994     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.01.010     Document Type: Conference Paper

References (15)

1. L.S. Ting, M.O. Benoit-Biancamano, O. Bernard Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance- associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study Pharmacotherapy 30 11 2010 1097 1108
2. N. Djebli, N. Picard, J.P. Rérolle Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients Pharmacogenet Genomics 17 5 2007 321 330
3. H. Michelon, J. König, A. Durrbach SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients Pharmacogenomics 11 12 2010 1703 1713
4. R.H. van Schaik, M. van Agteren, J.W. de Fijter UGTlA9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients Clin Pharmacol Ther 86 3 2009 319 327
5. N. Picard, D. Ratanasavanh, A. Premaud Identification of the UDP-glucuronosyltransferase isoformsinvolved in mycophenolic acid phase II metabolism Drug Metab Dispos 33 2005 139 146
6. Y. Duguay, C. Báár, F. Skorpen A novel functional polymorphism in the uridine diphosphate- glucuronosyltransferase 2B7 promoter with significant impact on promoter activity Clin Pharmacol Ther 75 3 2004 223 233
7. H. Feichtiger, E. Wieland, V.W. Armstrong The acyl glucuronide metabolite of mycophenolic acid induces tubulin polymerization in vitro Clin Biochem 43 1-2 2010 208 213
8. E. Wieland, M. Shipkova, U. Schellhaas Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 33 2 2000 107 113
9. B. Maes, M. Oellerich, J.L. Ceuppens A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis Nephrol Dial Transplant 17 5 2002 923 926
10. A.R. Asif, V.W. Armstrong, A. Voland Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats Biochimie 89 3 2007 393 402
11. M. Shipkova, V.W. Armstrong, L. Weber German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients Ther Drug Monit 24 3 2002 390 399
12. D. Wiener, J.L. Fang, N. Dossett Correlation between UDP- glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone glucuronidation phenotype in human liver microsomes Cancer Res 64 3 2004 1190 1196 Erratum in: Cancer Res. 2004;64(5):1899
13. O. Bernard, J. Tojcic, K. Journault Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid Drug Metab Dispos 34 2006 1539 1545
14. E. Levesque, R. Delage, M.O. Benoit-Biancamano The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers Clin Pharmacol Ther 81 2007 392 400
15. M. van Agteren, V.W. Armstrong, R.H. van Schaik AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism Ther Drug Monit 30 4 2008 439 444